Denosumab and Teriparatide Transitions in Postmenopausal Osteoporosis (The DATA-Switch Study): a Randomised Controlled Trial

BACKGROUND: Unlike most chronic diseases, approved osteoporosis treatments are generally limited to a single drug at a fixed dose and frequency. Nonetheless, no approved therapy is able to restore skeletal integrity in most osteoporotic patients and the long-term use of most osteoporosis drugs remai...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet
Main Authors: Leder, Benjamin Z., Tsai, Joy N., Uihlein, Alexander V., Wallace, Paul, Lee, Hang, Neer, Robert M., Burnett-Bowie, Sherri-Ann M.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4620731/
https://ncbi.nlm.nih.gov/pubmed/26144908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)61120-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki